IRVINE, Calif., Jan. 31, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie (NYSE: ABBV) company and a global leader in medical aesthetics treatments, released the "Decoding the Future of Aesthetic Individuality" report, which aims to deepen the understanding of the evolving consumer mix and their aesthetic needs. This report was commissioned to look at individuality through the lens of the aesthetics industry and how to support patients as they find and embrace their own personal definition of individuality when considering an aesthetic treatment.
"When it comes to self-expression, consumers have different objectives; we all make our own choices on how to be our true selves. Delivering on those expectations requires consumers to understand what options are possible, and providers to assess and apply different techniques. This variety demands expertise from providers and that's why we continue to invest in training and research to offer treatments that reflect individual aesthetic goals," said Carrie Strom, Global President of Allergan Aesthetics and SVP, AbbVie. "The findings in 'Decoding the Future of Aesthetic Individuality' help us to understand and support the evolving needs of aesthetic consumers."
This new report follows "The Future of Aesthetics Global Trends Report" launched by Allergan Aesthetics in 2022 that outlined 10 key trends set to shape the future of the aesthetics industry over the next 5 years. Individuality was featured as a key theme throughout the research.1 Individuality is a complex and multi-faceted concept, comprised of personal identity, inner motivations, needs, and the desire for self-expression and social connection.1
"As a practicing dermatologist, I know firsthand that no two patients and their experiences are alike. I was happy to be able to contribute to this report and develop a resource that provides insight for aesthetics professionals to better communicate with patients and ultimately help them to achieve their own individual look," said U.S. dermatologist Dr. Mona Gohara. "A focus on individuality -- as a practitioner and as a consumer – is critical when considering the patient's perspective and delivering desired patient outcomes."
The Findings
The findings recognize the personal needs of each patient should be at the forefront of every interaction across the patient journey.1 Key research themes included: understanding individuality, the impact of social media and the opportunity for aesthetics professionals to work towards personalized approaches to consultation and treatment.
Research included in the consumer survey found that:
Research brought to you by leading global experts
Decoding the Future of Aesthetic Individuality is formulated from robust and extensive research across consumer and business media, global social listening data, and market and industry reports from multiple geographies, specifically Brazil, China, Japan, UK and USA. Findings were validated through 1:1 interviews with some of the world's leading aesthetics practitioners** as well as experts in psychology, beauty, marketing, consumer behaviour and futures.***
To receive the Decoding the Future of Aesthetic Individuality report and for more information, please contact your local Allergan Aesthetics representative or download the report here.
Notes to Editors
About the Decoding the Future of Aesthetic Individuality report
The Decoding the Future of Aesthetic Individuality report was commissioned by Allergan Aesthetics, an AbbVie company, and developed by future think tank Wunderman Thompson Intelligence. It provides aesthetics practitioners and consumers with a deeper understanding of the concept of individuality and how the aesthetics industry can support patients in expressing their own.
Key opinion leaders who contributed to the report are:
Dr. Jonquille Chantrey, Aesthetic Surgeon, United Kingdom. Dr Mona Gohara, Dermatologist, United States. Dr Luiz Gustavo, Plastic Surgeon, Injectables Specialist, Brazil. Dr Kiyoko Kato, Surgeon and Cosmetologist, Japan. Dr Alex Box, Identity Designer and Beauty Futurist, United Kingdom. Rae Morris, Makeup Artist, Australia. Dr Marco Antonio Correa Varella, Experimental Psychologist, Brazil. Geraldine Wharry, Fashion Futurist, Advisor and Founder of the Trend Atelier, United Kingdom
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
About Wunderman Thompson Intelligence
Wunderman Thompson Intelligence is Wunderman Thompson's futurism, research and innovation unit. It charts emerging and future global trends, consumer change, and innovation patterns—translating these into insight for brands. It offers a suite of consultancy services, including bespoke research, presentations, co-branded reports and workshops. It is also active in innovation, partnering with brands to activate future trends within their framework and execute new products and concepts.
Footnotes:
** Dr. Jonquille Chantrey, Aesthetic Surgeon, United Kingdom. Dr Mona Gohara, Dermatologist, United States. Dr Luiz Gustavo, Plastic Surgeon, Injectables Specialist, Brazil. Dr Kiyoko Kato, Surgeon and Cosmetologist, Japan.
*** Dr Alex Box, Identity Designer and Beauty Futurist, United Kingdom. Rae Morris, Makeup Artist, Australia. Dr Marco Antonio Correa Varella, Experimental Psychologist, Brazil. Geraldine Wharry, Fashion Futurist, Advisor and Founder of the Trend Atelier, United Kingdom.
References
1 Allergan Aesthetics. "The Future of Aesthetics global trends report." May 2022. ALL-AGNA-220005
Last Trade: | US$173.02 |
Daily Change: | -9.91 -5.42 |
Daily Volume: | 5,060,692 |
Market Cap: | US$306.250B |
December 11, 2024 December 09, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB